標(biāo)題: Titlebook: Comprehensive Diagnostic Approach to Bladder Cancer; Molecular Imaging an Marc A. Bjurlin,Richard S. Matulewicz Book 2021 The Editor(s) (if [打印本頁] 作者: T-cell 時間: 2025-3-21 17:15
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer影響因子(影響力)
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer影響因子(影響力)學(xué)科排名
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer網(wǎng)絡(luò)公開度
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer被引頻次
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer被引頻次學(xué)科排名
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer年度引用
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer年度引用學(xué)科排名
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer讀者反饋
書目名稱Comprehensive Diagnostic Approach to Bladder Cancer讀者反饋學(xué)科排名
作者: 取之不竭 時間: 2025-3-22 00:17 作者: 外觀 時間: 2025-3-22 03:30 作者: LANCE 時間: 2025-3-22 06:48
Stem Cell Sources for Regenerative Medicineluate whether PET imaging can predict or accurately assess treatment response. .Tc-MDP or .F-NaF radiotracers permit assessment of bone metastases, with limitations of each modality. Several novel radiotracers are under investigation for future utility.作者: Bother 時間: 2025-3-22 10:14
Asmin Tulpule,George Q. Daley MD, PhDstic strategies are now recommended. This chapter summarizes the definitions, etiologies, and risk classifications algorithms for hematuria as well as the data supporting various evaluation strategies.作者: 察覺 時間: 2025-3-22 14:42
Julie Audet,William L. Stanforddata by making moderate and conditional recommendations for the use of blue light cystoscopy and narrow-band imaging, respectively. Future directions for enhanced cystoscopy include more prospective, randomized trials evaluating cancer-specific survival and the use of Cysview as a cytotoxic treatment modality.作者: 察覺 時間: 2025-3-22 20:28 作者: 駭人 時間: 2025-3-23 00:30
Evaluation of Hematuria,stic strategies are now recommended. This chapter summarizes the definitions, etiologies, and risk classifications algorithms for hematuria as well as the data supporting various evaluation strategies.作者: 旁觀者 時間: 2025-3-23 04:08
Optical Techniques for Bladder Cancer Detection: The Role of Cystoscopy and Enhanced Cystoscopy,data by making moderate and conditional recommendations for the use of blue light cystoscopy and narrow-band imaging, respectively. Future directions for enhanced cystoscopy include more prospective, randomized trials evaluating cancer-specific survival and the use of Cysview as a cytotoxic treatment modality.作者: Constant 時間: 2025-3-23 08:15
Bladder Cancer Genomics: Indications for Sequencing and Diagnostic Implications,ded to include both plasma and urine, new avenues to screen and monitor disease are becoming available. While current guidelines recommend sequencing only for patients with advanced and metastatic disease, currently active clinical trials may expand these indications in the near future.作者: 烤架 時間: 2025-3-23 10:13 作者: instructive 時間: 2025-3-23 16:16
Stem Cells in Neuroendocrinology with various cancer-related mechanisms to predispose to bladder cancer. Germline predisposition as part of characterized pathogenic mutations in cancer-associated genes (e.g., BRCA1/2 and MMR-deficiency) is also an increasingly recognized mechanism of bladder cancer carcinogenesis.作者: 附錄 時間: 2025-3-23 21:10
Stem Cells in Regenerative Medicineionally, bladder cancer staging with MRI and recently proposed Vesicle Imaging-Reporting and Data System (VI-RADS) are also explained. Newly developing radiomics techniques for the assessment for bladder cancer with future directions are also discussed.作者: 透明 時間: 2025-3-24 01:09 作者: Clumsy 時間: 2025-3-24 05:12 作者: 過分 時間: 2025-3-24 08:18 作者: aquatic 時間: 2025-3-24 11:44 作者: 表臉 時間: 2025-3-24 18:33 作者: Resection 時間: 2025-3-24 20:20 作者: Organization 時間: 2025-3-25 02:18
Staging of Bladder Cancer, dependent on diagnostic capabilities and surgical biopsy/resection techniques. Cystoscopy is the mainstay of bladder cancer workup with urine cytology and cystoscopic enhancement serving as adjuncts to cancer detection. After tumor identification, transurethral resection is done to obtain tissue. R作者: 雪崩 時間: 2025-3-25 06:03 作者: TAP 時間: 2025-3-25 09:42
Evaluation of Hematuria,s either gross (visible) or microscopic (not visible). Patients with gross hematuria have a much higher likelihood of an underlying malignant cause and generally require prompt evaluation. Alternatively, the definition of clinically significant microscopic hematuria varies among different specialtie作者: 熱情的我 時間: 2025-3-25 12:41
Molecular Imaging Modalities: Applications of Current and Novel Radiotracers, or assessment of distant metastatic disease but is of limited utility for primary tumor staging due to urinary excretion of the radiotracer. .C-choline and .C-acetate both overcome the issue of urinary excretion, but their short half-life necessitates an onsite cyclotron. Ongoing studies aim to eva作者: 獨(dú)白 時間: 2025-3-25 17:06 作者: 即席演說 時間: 2025-3-25 21:08
Urine Cytology in the Clinical Management of Bladder Cancer,e diagnosis and surveillance of urothelial malignancies. Advances in cytopathological technique as well as the advent of robust classification systems such as the Paris System have led to improvements in the diagnostic accuracy and reliability of urinary tract cytology to identify clinically signifi作者: Conducive 時間: 2025-3-26 02:57
Urinary Biomarkers: Current Status and Future Opportunities,. Adjunctive cytology, which has acceptable performance for detection of high-grade lesions but not for low-grade lesions, suffers from significant interobserver and inter-institutional variability. In addition, an atypical cytology adds diagnostic uncertainty especially in the surveillance setting.作者: Condense 時間: 2025-3-26 05:54 作者: 開始從未 時間: 2025-3-26 11:21
Novel and Investigational Diagnostics: Liquid Biopsy and Beyond,c diagnostic technologies have enabled the isolation and characterization of several different types of tumor-derived materials that are shed into the peripheral blood of cancer patients, including circulating tumor cells and cell-free circulating tumor DNA. As a noninvasive means of detecting and m作者: 可耕種 時間: 2025-3-26 14:34 作者: 名字的誤用 時間: 2025-3-26 20:30
Comprehensive Diagnostic Approach to Bladder CancerMolecular Imaging an作者: HALO 時間: 2025-3-26 23:56
Comprehensive Diagnostic Approach to Bladder Cancer978-3-030-82048-0作者: 亞當(dāng)心理陰影 時間: 2025-3-27 01:47 作者: Maximize 時間: 2025-3-27 08:39 作者: meretricious 時間: 2025-3-27 09:46
Urinary Biomarkers: Current Status and Future Opportunities,rine biomarkers are attractive due to the simplicity of specimen collection anddirect contact of urine with the urothelial tumor; they have the potential to improve diagnosis, reduce unnecessary cystoscopies, and risk-stratify patients in both diagnostic and surveillance settings. The current status作者: right-atrium 時間: 2025-3-27 14:18 作者: Facilities 時間: 2025-3-27 20:38 作者: 討好女人 時間: 2025-3-27 23:59
J. Kehler,K. Hübner,H. R. Sch?lerma of the bladder, but not in low-risk disease. Likewise, urinary tract cytology is not recommended in the evaluation of patients with microscopic hematuria but may be considered in patients with gross hematuria. Although cystoscopy continues to be the gold standard for diagnosis and surveillance of作者: 噴油井 時間: 2025-3-28 03:57
https://doi.org/10.1007/3-540-31437-7rine biomarkers are attractive due to the simplicity of specimen collection anddirect contact of urine with the urothelial tumor; they have the potential to improve diagnosis, reduce unnecessary cystoscopies, and risk-stratify patients in both diagnostic and surveillance settings. The current status作者: MOAT 時間: 2025-3-28 07:06 作者: accrete 時間: 2025-3-28 10:33
Hiroko Nakahama,Elisa Di Pasqualesparities in the diagnosis, treatment, and prognosis of bladder cancer, with particular focus on gender, race, insurance, and geography as important determinants of outcome. We also discuss the burden of financial toxicity in the management of muscle- and non-muscle-invasive bladder cancer for young作者: Ornament 時間: 2025-3-28 14:39 作者: muscle-fibers 時間: 2025-3-28 19:13
Asmin Tulpule,George Q. Daley MD, PhD dependent on diagnostic capabilities and surgical biopsy/resection techniques. Cystoscopy is the mainstay of bladder cancer workup with urine cytology and cystoscopic enhancement serving as adjuncts to cancer detection. After tumor identification, transurethral resection is done to obtain tissue. R作者: floodgate 時間: 2025-3-29 01:17 作者: Ataxia 時間: 2025-3-29 06:29 作者: 褲子 時間: 2025-3-29 09:01
Stem Cell Sources for Regenerative Medicine or assessment of distant metastatic disease but is of limited utility for primary tumor staging due to urinary excretion of the radiotracer. .C-choline and .C-acetate both overcome the issue of urinary excretion, but their short half-life necessitates an onsite cyclotron. Ongoing studies aim to eva作者: 沉思的魚 時間: 2025-3-29 12:45 作者: deficiency 時間: 2025-3-29 19:08 作者: staging 時間: 2025-3-29 19:48 作者: Herpetologist 時間: 2025-3-30 01:50
J. Morser,S. -I. Nishikawa,H. R. Sch?lerbility and reduced costs of next-generation sequencing has resulted in an improved understanding of the molecular biology of bladder cancer. Data from genomic sequencing yield prognostic information that may aid in the decision to pursue aggressive therapies, as well as predictive information regard作者: 治愈 時間: 2025-3-30 06:46
https://doi.org/10.1007/978-3-030-90111-0c diagnostic technologies have enabled the isolation and characterization of several different types of tumor-derived materials that are shed into the peripheral blood of cancer patients, including circulating tumor cells and cell-free circulating tumor DNA. As a noninvasive means of detecting and m作者: 犬儒主義者 時間: 2025-3-30 11:27
https://doi.org/10.1007/978-3-030-82048-0imaging modalities; cancer staging; tumor markers; molecular markers; cancer detection
